TGTX
Tg Therapeutics Inc
$13.83
Earnings Summary
Revenue | $165.82Mn |
Net Profits | $113.93Mn |
Net Profit Margins | 68.71% |
Highlights
Tg Therapeutics Inc’s revenue jumped 176298.94% since last year same period to $165.82Mn in the Q3 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated 931.57% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 410.66% since last year same period to $113.93Mn in the Q3 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated 339.3% jump in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 100.18% since last year same period to 68.71% in the Q3 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated 123.2% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Tg Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.12 |
EPS Estimate Current Year | -0.12 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.12 - a -200% fall from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.12.
Key Ratios
Key ratios of the Tg Therapeutics Inc post its Q3 2023 earnings
Earning Per Share (EPS) | 0.73 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) jumped 380.77% since last year same period to 0.73 in the Q3 2023. This indicates that the Tg Therapeutics Inc has generated 380.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-06 | 0.12 | 0.73 | 508.33% |
2023-08-04 | -0.25 | -0.34 | -36% |
2023-05-08 | -0.37 | -0.28 | 24.32% |
₹0 US Stocks a/c Opening Fee